It's World's Alzheimer's Day! Please take the opportunity to watch the TVO episode this evening airing 'Much Too Young' along with an
New updates released today by Biogen on its Phase 1b long term extension study of aducanumab in mild cognitive impairment and mild Alzheimer's disease
Call us at 416-386-9606 and speak to our clinical trial educator for more details.
Join us for the next Alzheimer Society of Toronto Speaker Series on Wednesday, September 6 as Dr. Sharon Cohen discusses, "What Will It Take to End
COGNIGRAM cognitive assessment system has been approved by the FDA. This memory assessment tool has been available at Toronto Memory Program for over
Stay updated and learn about what's new in Alzheimer's research! Register today to take advantage of this free